TMCnet News
Blueair's HealthProtect™ Becomes First Air Purifier from Major Brand Tested to Remove Live SARS-CoV-2 Virus from AirBlueair, a global air purification expert, confirmed today its HealthProtect™ 7400 air purifier removed 99.99%i of live airborne SARS-CoV-2 virus in controlled biosafety level 3 lab testing. The test was conducted by MRIGlobal, an independent non-profit research organization, in a 13ft³ chamber on live aerosolized SARS-CoV-2 virus. With today's announcement, Blueair's HealthProtect air purifier has become the first product from a majorii air purifier brand tested to remove the live SARS-CoV-2 virus from the air. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210412005621/en/ (Photo: Business Wire) "At Blueair we are proud to be an industry leader in performance testing," said Jonas Holst, Chief Product Officer. "Blueair has built its position as a leader within the air purification industry by 25 years of independent third-party testing of all innovations. Today there is no surprise that a fear of COVID-19 is driving demand for air purifiers, and as such, our commitment as a brand needs to deliver honest, factual, results on live SARS-CoV-2 virus that consumers can trust." In addition to removing the airborne SARS-CoV-2 virus from the air, Blueair's most advanced air purifier ever, HealthProtect™, is the only air purifier to provide 24/7 protection against viruses and bacteriaiii, allowing you to feel reassured about the air your family breathes each day. HealthProtect™ state-of-the-art technologies include:
To learn more about Blueair's test conducted by MRIGlobal visit www.blueair.com/us/coronavirus.html. About Blueair Blueair is a world-leading producer of air purification solutions for home and professional use. Founded in Sweden, Blueair delivers innovative, energy-efficient products that are sold in over 60 countries around the world. Blueair is part of the Unilever family of brands, www.blueair.com. About MRIGlobal MRIGlobal addresses some of the world's greatest threats and challenges. Founded in 1944 as an independent, non-profit organization, we perform contract research for government, industry, and academia. Our customized solutions in national security and defense and health include research and development capabilities in clinical research support, infectious disease and biological threat agent detection, global biological engagement, in vitro diagnostics, and laboratory management and operations. MRIGlobal is one of two partners in the Alliance for Sustainable Energy, LLC, which manages and operates the National Renewable Energy Laboratory (NREL) in Golden, Colorado, for the U.S. Department of Energy. For more information, visit mriglobal.org.
iTested in a 13ft³ chamber only on a Blueair HealthProtect 7400. HealthProtect has not been proven to kill SARS-CoV-2 or reduce or prevent the transmission of COVID-19.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210412005621/en/ |